Astria Therapeutics to present at upcoming European Academy of Dermatology and Venerology Congress
Astra Therapeutics today announced that it will present initial navenibart ALPHA-STAR data at the upcoming European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, the Netherlands on 26 September 2024.
Raffi Tachdjian, MD MPH, Associate Clinical Professor of Medicine and Pediatrics in the Division of Allergy and Clinical Immunology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), will present a poster titled “ALPHA-STAR, a Phase 1b/2 Clinical Trial of Single and Multiple Doses of STAR-0215 in Patients with Hereditary Angioedema: Initial Safety and Efficacy Outcomes.”
The poster will be presented in e-poster showcase six on Thursday 26 September 2024 at 4:20pm Central European Summer Time (CEST).
(Source: Astria)
